An end to breast cancer?
-
I'll wait for @bachophile to chime in here. He's the expert on breast cancer.
But...
16 people, and the headline screams "End to Breast Cancer?"
Not saying that it's an unimportant step, but...16 people. Next year 600.
"Triple negative accounts for 10-15% of breast carcinomas.
Still, an important step. My dorm-mate from school (who used to head the oncology dept at Northwestern) always said that immunology is the future of cancer therapy.
-
Oh jeez, the company’s PR ad man hyperbole is probably making him a big hero among the investors, but that is so far from reality.
All they show in their press release is that their vaccine generated an immune response. No connection or mention of disease response or any clinical parameter.
It’s ridiculous hyperbole, timed to the San Antonio breast cancer symposium, a conf which I have gone to regularly but can’t this year because no surgeons are allowed to get time off from the hospital, (so no Texas barbecue for me this year) to attract investors.
Not to say that immune oncology is not important but this particular study is so preliminary that it’s not even really been shown to affect cancer.
anyway…some people ( copy writers) really have no shame
-
Oh jeez, the company’s PR ad man hyperbole is probably making him a big hero among the investors, but that is so far from reality.
All they show in their press release is that their vaccine generated an immune response. No connection or mention of disease response or any clinical parameter.
It’s ridiculous hyperbole, timed to the San Antonio breast cancer symposium, a conf which I have gone to regularly but can’t this year because no surgeons are allowed to get time off from the hospital, (so no Texas barbecue for me this year) to attract investors.
Not to say that immune oncology is not important but this particular study is so preliminary that it’s not even really been shown to affect cancer.
anyway…some people ( copy writers) really have no shame
@bachophile said in An end to breast cancer?:
Oh jeez, the company’s PR ad man hyperbole is probably making him a big hero among the investors, but that is so far from reality.
All they show in their press release is that their vaccine generated an immune response. No connection or mention of disease response or any clinical parameter.
It’s ridiculous hyperbole, timed to the San Antonio breast cancer symposium, a conf which I have gone to regularly but can’t this year because no surgeons are allowed to get time off from the hospital, (so no Texas barbecue for me this year) to attract investors.
Not to say that immune oncology is not important but this particular study is so preliminary that it’s not even really been shown to affect cancer.
anyway…some people ( copy writers) really have no shame
Thank you.
